Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07059364Not ApplicableRecruiting

Empowering Caregivers to Promote Child Independence

Role: collaborator

NCT03718936Recruiting

ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Role: collaborator

NCT03718923Recruiting

FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Role: collaborator

NCT02428205Not ApplicableCompleted

Combined Effects of Early Behavioral Intervention and Propranolol on ASD

Role: collaborator

NCT01970345Phase 2Terminated

A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder

Role: collaborator

NCT00947700Not ApplicableCompleted

Early Connections, Early Detection and Intervention in Infants at Risk for Autism

Role: collaborator

All 6 trials loaded